Tovorafenib, Tovorafenib clinical trials

PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

This study is testing a new medicine called Tovorafenib for children and young adults with a brain tumour called craniopharyngioma. We want to see if it stops the tumour from growing and how it affects their quality of life over 12 months.